Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-011504

SOLENO THERAPEUTICS INC · SLNO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
David D O'Toole
Officer — See Remarks
Period of report
Jan 10, 2016
Accepted (ET)
Jan 11, 2016 · 8:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock OptionF1,F2,F3,F4,F5,F6$1.61Jan 10, 2016A60,000AJan 10, 2016Jan 10, 2026Common Stock60,00060,000D

Explanation of responses

Remarks

Senior Vice President, Chief Financial Officer